- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- homo-tetramer
- Ligands
- 9 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 3 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.4: 4 residues within 4Å:- Chain A: D.267, W.278, S.280, E.285
No protein-ligand interaction detected (PLIP)PEG.5: 7 residues within 4Å:- Chain A: S.157, G.158, N.159, L.235, I.271, G.272, S.273
No protein-ligand interaction detected (PLIP)PEG.10: 4 residues within 4Å:- Chain B: S.121, Q.125, K.152, Y.153
No protein-ligand interaction detected (PLIP)- 1 x M2M: 1-METHOXY-2-(2-METHOXYETHOXY)ETHANE(Non-covalent)
- 3 x SAO: 5'-S-[(3S)-3-azaniumyl-3-carboxypropyl]-5'-thioadenosine(Non-covalent)
SAO.7: 27 residues within 4Å:- Chain A: F.12, R.15, Y.24, F.25, Y.28, Q.34, M.37, R.43, D.65, G.67, C.68, G.69, S.70, I.72, L.73, V.88, E.89, A.90, S.91, G.115, K.116, V.117, E.118, E.132, M.143, S.146
- Ligands: M2M.6
12 PLIP interactions:12 interactions with chain A- Hydrogen bonds: A:Q.34, A:Q.34, A:G.67, A:G.69, A:E.89, A:E.89, A:A.90, A:S.91, A:V.117, A:E.118
- Salt bridges: A:R.43
- pi-Stacking: A:F.25
SAO.15: 29 residues within 4Å:- Chain C: F.12, R.15, Y.24, F.25, Y.28, Q.34, M.37, M.38, R.43, D.65, G.67, C.68, G.69, S.70, G.71, I.72, L.73, V.88, E.89, A.90, S.91, G.115, K.116, V.117, E.118, E.132, P.133, M.143, S.146
12 PLIP interactions:12 interactions with chain C- Hydrogen bonds: C:Q.34, C:G.67, C:G.69, C:E.89, C:E.89, C:A.90, C:S.91, C:V.117, C:E.118
- Water bridges: C:E.132
- Salt bridges: C:R.43
- pi-Stacking: C:F.25
SAO.17: 27 residues within 4Å:- Chain D: F.12, Y.24, F.25, Y.28, Q.34, M.37, R.43, D.65, G.67, C.68, G.69, S.70, G.71, I.72, L.73, V.88, E.89, A.90, S.91, G.115, K.116, V.117, E.118, E.132, P.133, M.143, S.146
12 PLIP interactions:12 interactions with chain D- Hydrogen bonds: D:Q.34, D:Q.34, D:G.67, D:G.69, D:E.89, D:E.89, D:A.90, D:V.117, D:E.118
- Water bridges: D:E.132
- Salt bridges: D:R.43
- pi-Stacking: D:F.25
- 1 x 6CZ: 5'-{[(3S)-3-amino-3-carboxypropyl](3-ethoxy-2,3-dioxopropyl)amino}-5'-deoxyadenosine(Non-covalent)
6CZ.11: 31 residues within 4Å:- Chain B: Y.24, F.25, Y.28, Q.33, Q.34, M.37, R.43, G.67, C.68, G.69, S.70, I.72, L.73, V.88, E.89, A.90, S.91, G.115, K.116, V.117, E.118, E.132, P.133, M.134, G.135, Y.136, E.141, M.143, S.146, H.289, W.290
14 PLIP interactions:14 interactions with chain B- Hydrogen bonds: B:Y.24, B:Q.34, B:G.67, B:G.69, B:E.89, B:E.89, B:A.90, B:V.117, B:E.118, B:W.290
- Salt bridges: B:R.43, B:E.132, B:H.289
- pi-Stacking: B:F.25
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cura, V. et al., Crystal structure of mouse CARM1 in complex with inhibitor SA0592. To Be Published
- Release Date
- 2017-03-15
- Peptides
- Histone-arginine methyltransferase CARM1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- homo-tetramer
- Ligands
- 9 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 3 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 1 x M2M: 1-METHOXY-2-(2-METHOXYETHOXY)ETHANE(Non-covalent)
- 3 x SAO: 5'-S-[(3S)-3-azaniumyl-3-carboxypropyl]-5'-thioadenosine(Non-covalent)
- 1 x 6CZ: 5'-{[(3S)-3-amino-3-carboxypropyl](3-ethoxy-2,3-dioxopropyl)amino}-5'-deoxyadenosine(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cura, V. et al., Crystal structure of mouse CARM1 in complex with inhibitor SA0592. To Be Published
- Release Date
- 2017-03-15
- Peptides
- Histone-arginine methyltransferase CARM1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D